MRK - Merck & Co Inc Stock Analysis
Merck & Co Inc (MRK) is a publicly traded company listed on the Mega. It operates in the Drug Manufacturers - General industry, part of the broader Healthcare sector. The company has a market capitalization of 294.03B, generates annual revenue of 65.51B, and reports net income of 8.94B. As of the latest data, the stock is trading at 119.05 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company uses a significant amount of debt to finance its operations, which can boost returns but adds financial risk. The stock offers a moderate dividend yield (2.7%), which may appeal to income-focused investors. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Hold (3.94), indicating current market sentiment. Institutional ownership is reported at 81.01%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 45.50%, trading within a 52-week range of 76.66 - 125.14.
MRK - Merck & Co Inc
119.05
Analyst Consensus
Hold 3.94
MRK – Analyst Rating Summary
- Strong Buy: 9
- Buy: 16
- Hold: 11
- Sell: 0
- Strong Sell: 0
- Total Analysts: 36
| Index: | DJIA, S&P 500 | P/E: | 33.51 | EPS (ttm): | 3.55 | Insider Own: | 0.18% | Shs Outstand: | 2.47B | Perf Week: | -1.44% |
| Market Cap: | 294.03B | Forward P/E: | 12.35 | EPS next Y: | 9.64 | Insider Trans: | -7.11% | Shs Float: | 2.47B | Perf Month: | 4.94% |
| Income(ttm): | 8.94B | PEG: | 2.06 | EPS next Q: | 2.11 | Inst Own: | 81.01% | Short Float: | 1.24% | Perf Quarter: | 2.98% |
| Revenue(ttm): | 65.51B | P/S: | 4.49 | EPS this Y: | -42.78% | Inst Trans: | -0.56% | Short Ratio: | 3.13 | Perf Half Y: | 21.95% |
| Book/sh: | 18.58 | P/B: | 6.41 | EPS next Y: | 87.60% | ROA: | 7.33% | Short Interest: | 30.55M | Perf Year: | 45.50% |
| Cash/sh: | 2.34 | P/C: | 50.93 | EPS next 5Y: | 5.99% | ROE: | 18.97% | 52W Range: | 76.66 - 125.14 | Perf YTD: | 13.10% |
| Dividend Est.: | 3.21 (2.70%) | P/FCF: | 20.83 | EPS past 3/5Y: | 8.43% 21.23% | ROIC: | 9.65% | 52W High: | 125.14 -4.87% | Beta: | 0.21 |
| Dividend TTM: | 3.32 (2.79%) | Quick Ratio: | 1.06 | Sales past 3/5Y: | 3.55% 9.34% | Gross Margin: | 73.44% | 52W Low: | 76.66 55.30% | Perf 5Y: | 56.09% |
| Dividend Ex-Date: | Jun 15, 2026 | Current Ratio: | 1.30 | EPS Y/Y TTM: | -48.28% | Oper. Margin: | 27.50% | RSI (14): | 54.22 | Volatility: | 2.53% 2.41% |
| Employees: | 75000 | Debt/Eq: | 1.07 | Sales Y/Y TTM: | 2.70% | Profit Margin: | 13.64% | Recom: | 1.70 | Target Price: | 131.83 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 1.02 | EPS Q/Q: | -185.47% | Payout: | 45.05% | Rel Volume: | 1.12 | Prev Close: | 120.76 |
| Sales Surprise: | 2.77% | EPS Surprise: | 13.15% | Sales Q/Q: | 3.72% | Earnings: | Apr 30 BMO | Avg Volume: | 9.76M | Price: | 119.05 |
| SMA20: | 1.21% | SMA50: | 2.47% | SMA200: | 13.62% | Undervalued: 10.73% | Volume: | 10,923,686 | Change: | -1.42% | |
Graham Classic formula value: 65.29
(P/E=8 * 1g) Min value: 44.6
(current P/E * 2g) Max value: 145.01
Average value: 84.97
About Merck & Co Inc
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.